ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,890,245 | +72.2% | 2,206,715 | +95.0% | 0.16% | +85.1% |
| Q2 2023 | $34,788,335 | +454.0% | 1,131,696 | +549.3% | 0.09% | +383.3% |
| Q1 2023 | $6,279,453 | -63.9% | 174,284 | -60.4% | 0.02% | -67.3% |
| Q4 2022 | $17,393,108 | -45.3% | 440,109 | -44.4% | 0.06% | -49.1% |
| Q3 2022 | $31,796,000 | +60.6% | 791,340 | +68.0% | 0.11% | +66.2% |
| Q2 2022 | $19,799,000 | +171.7% | 470,947 | +151.8% | 0.06% | +195.5% |
| Q1 2022 | $7,287,000 | +13.7% | 187,027 | +16.3% | 0.02% | +57.1% |
| Q4 2021 | $6,407,000 | – | 160,775 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |